Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission
David W. Eyre, Donald Taylor, M. B. Purver, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Xuemei He, Weiqi Hong, Xiangyu Pan, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 838-845
Open Access | Times Cited: 494
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, et al.
Science (2021) Vol. 375, Iss. 6578, pp. 331-336
Open Access | Times Cited: 241
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e229317-e229317
Open Access | Times Cited: 203
Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
Daniel Ayoubkhani, Matthew L. Bosworth, Sasha King, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 128
Shedding of Infectious SARS-CoV-2 Despite Vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 117
Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination
Michael Klompas
JAMA (2021) Vol. 326, Iss. 20, pp. 2018-2018
Closed Access | Times Cited: 78
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
Piotr Rzymski, Carlos A. Camargo, Andrzej Fal, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1299-1299
Open Access | Times Cited: 76
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
Brechje de Gier, Stijn P. Andeweg, Jantien A. Backer, et al.
Eurosurveillance (2021) Vol. 26, Iss. 44
Open Access | Times Cited: 69
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Bo Meng, Isabella A. T. M. Ferreira, Adam Abdullahi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 57
Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein
Huaying Zhao, Ai Nguyen, Di Wu, et al.
PNAS Nexus (2022) Vol. 1, Iss. 2
Open Access | Times Cited: 53
Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study
Maylis Layan, Mayan Gilboa, Tal Gonen, et al.
American Journal of Epidemiology (2022) Vol. 191, Iss. 7, pp. 1224-1234
Open Access | Times Cited: 51
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Ravindra K. Gupta
Research Square (Research Square) (2022)
Open Access | Times Cited: 47
What do we know about covid vaccines and preventing transmission?
Chris Stokel-Walker
BMJ (2022), pp. o298-o298
Open Access | Times Cited: 45
The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases
Michal Stein, Liat Ashkenazi‐Hoffnung, David Greenberg, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 81-81
Open Access | Times Cited: 38
Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
Rachel M. Burckhardt, John J. Dennehy, Leo L. M. Poon, et al.
Journal of Virology (2021) Vol. 96, Iss. 3
Open Access | Times Cited: 47
Biocompatible Films of Calcium Alginate Inactivate Enveloped Viruses Such as SARS-CoV-2
Alba Cano-Vicent, Rina Hashimoto, Kazuo Takayama, et al.
Polymers (2022) Vol. 14, Iss. 7, pp. 1483-1483
Open Access | Times Cited: 30
Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study
Daniel Ayoubkhani, Matthew L. Bosworth, Sasha King, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 28
Estimation of the basic reproduction number of Alpha and Delta variants of COVID-19 pandemic in Iran
Farnaz Sheikhi, Negar Yousefian, Pardis Tehranipoor, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0265489-e0265489
Open Access | Times Cited: 28
COVID-19 Vaccination and Rates of Infections, Hospitalizations, ICU Admissions, and Deaths in the European Economic Area during Autumn 2021 Wave of SARS-CoV-2
Dominika Sikora, Piotr Rzymski
Vaccines (2022) Vol. 10, Iss. 3, pp. 437-437
Open Access | Times Cited: 27
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
Stacey Orangi, John Ojal, Samuel P. C. Brand, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e009430-e009430
Open Access | Times Cited: 27
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
Samuel Clifford, Pauline Waight, Jada Hackman, et al.
Wellcome Open Research (2023) Vol. 8, pp. 96-96
Open Access | Times Cited: 14
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant
Charlotte B. Acharya, John Schrom, Anthea Mitchell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top